SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

SLN.L News

IN BRIEF: Silence Therapeutics to delist from AIM next week
26 Nov 2021

IN BRIEF: Silence Therapeutics to delist from AIM next week

IN BRIEF: Silence Therapeutics to delist from AIM next week

Silence Therapeutics to proceed with AIM delisting next week
26 Nov 2021

Silence Therapeutics to proceed with AIM delisting next week

(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced o...

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note
16 Nov 2021

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

Revenue, expenses rise in third quarter for Silence Therapeutics
16 Nov 2021

Revenue, expenses rise in third quarter for Silence Therapeutics

(Sharecast News) - Silence Therapeutics said on Tuesday that its revenue increased by £1.2m year-on-year in its third quarter, as a result of the...

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics
5 Nov 2021

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

Frazier Life Sciences becomes 'important' new Silence Therapeutics shareholder
5 Nov 2021

Frazier Life Sciences becomes 'important' new Silence Therapeutics shareholder

(Sharecast News) - Novel short interfering ribonucleic acid (siRNA) therapy developer Silence Therapeutics announced on Friday that healthcare-focusse...

UK shareholder meetings calendar - next 7 days
25 Oct 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

IN BRIEF: Silence Therapeutics reports solid progress across pipelines
22 Oct 2021

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

IN BRIEF: Silence Therapeutics reports solid progress across pipelines